Table 3.
Inhibition of Cell Proliferation (%) ± SEM [Calculated IC50 (μM)] | ||||
---|---|---|---|---|
Compound | Conc. | SiHa | HeLa | MDA-MB-231 |
Chlorojanerin (1) | 10 μM | 82.10 ± 0.97 | 51.83 ± 2.43 | 90.55 ± 1.27 |
30 μM | 92.93 ± 0.35 | 77.08 ± 0.80 | 92.00 ± 0.68 | |
[6.71] | [11.37] | [2.21] | ||
19-Deoxychlorojanerin (2) | 10 μM | 90.93 ± 1.32 | 96.17 ± 0.38 | 96.14 ± 0.51 |
30 μM | 95.80 ± 0.15 | 96.14 ± 0.48 | 97.42 ± 0.36 | |
[5.54] | [4.86] | [2.88] | ||
15-Hydroxyjanerin (3) | 10 μM | <10 | <10 | <10 |
30 μM | <10 | <10 | <10 | |
Aguerin B (4) | 10 μM | 89.09 ± 1.54 | 28.87 ± 0.83 | 96.23 ± 0.45 |
30 μM | 97.92 ± 0.41 | 97.50 ± 0.31 | 96.64 ± 0.71 | |
[5.70] | [12.64] | [4.26] | ||
Cynaropicrin (5) | 10 μM | 63.03 ± 1.25 | 34.36 ± 2.37 | 92.16 ± 0.68 |
30 μM | 90.75 ± 0.55 | 68.26 ± 1.85 | 93.45 ± 0.27 | |
[8.39] | [12.99] | [4.80] | ||
Eleganin (6) | 10 μM | 64.97 ± 2.06 | 16.54 ± 1.48 | 89.44 ± 1.36 |
30 μM | 90.89 ± 0.43 | 73.99 ± 1.68 | 92.09 ± 0.9 | |
[7.57] | [19.62] | [6.86] | ||
Apigenin | 10 μM | <10* | 18.81 ± 0.80 | <10 |
30 μM | 29.92 ± 1.75 | 70.43 ± 1.09 | 28.42 ± 1.04 | |
Jaceosidine | 10 μM | 18.88 ± 2.99 | <10 | <10 |
30 μM | 60.08 ± 0.74 | 75.18 ± 0.68 | 40.04 ± 1.68 | |
6-Methoxyluteolin | 10 μM | 14.16 ± 1.49 | 88.00 ± 0.63 | <10 |
30 μM | 35.20 ± 2.08 | 93.74 ± 0.65 | 26.55 ± 2.12 | |
[4.50] | ||||
Scopoletin | 10 μM | <10 | <10 | 12.09 ± 2.59 |
30 μM | 17.18 ± 2.18 | <10 | 15.85 ± 1.85 | |
Cisplatin | 10 μM | 88.64 ± 0.50 | 42.61 ± 2.33 | 67.51 ± 1.01 |
30 μM | 90.18 ± 1.78 | 99.93 ± 0.26 | 87.75 ± 1.10 | |
[7.84] | [12.43] | [3.74] |
* Antiproliferative activities less than 10% are considered negligible and not given numerically.